Effect of Colloid Versus Crystalloid on Coagulation in Elective Urological Surgery
NCT ID: NCT02009033
Last Updated: 2013-12-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
40 participants
INTERVENTIONAL
2011-09-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The secondary goal is to register blood loss and use of blood products during operation.
The trial concerns 40 patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ringer's lactate
Fluid therapy during operation
Lactated Ringer
When normovolæmic status of the patient is secured, 35 ml/kg of the allocated fluid is infused during the operation (estimated time for this type of operation is 180 minutes), however max. 3500 ml.Lactated Ringer is the interventional medication.
Hydroxyethylstarch
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lactated Ringer
When normovolæmic status of the patient is secured, 35 ml/kg of the allocated fluid is infused during the operation (estimated time for this type of operation is 180 minutes), however max. 3500 ml.Lactated Ringer is the interventional medication.
Hydroxyethylstarch
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Indication for elective surgery with removal of the urine bladder.
* Patient without anticoagulative, acethylsalisylsyre or NSAID medicine during the last 5 days,if using.
Exclusion Criteria
* Renal insufficiency demanding dialysis
* Manifest cardiac and hepatic insufficiency
* Disturbance in coagulation
* Hypernatriæmi
* Hyperchloræmi
* Pregnant or nursing
* Allergic to hydroxyethylstarch
* Participating in another trial-if interferring the present trial
* Incapable of managing his own affairs.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
K. C. Rasmussen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
K. C. Rasmussen
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Niels Henry Secher, Professor
Role: STUDY_CHAIR
Rigshospitalet , Dept. 2042, 2100 Copenhagen
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-2-2011-063
Identifier Type: -
Identifier Source: org_study_id